Skip to content
Search

Latest Stories

People infected with Helicobacter pylori bacterium have higher Alzheimer’s risk

People infected with Helicobacter pylori bacterium have higher Alzheimer’s risk

Around 40 per cent of Britons carry this common stomach bug that is found in contaminated water, food and soil

Researchers at McGill University in Montreal have estimated that about 200,000 cases of Alzheimer’s could be prevented each year by eradicating Helicobacter pylori bacterium, a common stomach bug carried by two in three people worldwide.


In a study, they have found symptomatic Helicobacter pylori infection associated with “moderate but significant” risk of contracting Alzheimer’s, The Times reported.

The risk of contracting Alzheimer’s was 11 per cent higher in adults infected with the bacterium, and it went up to 24 per cent between seven to ten years after the original infection took place.

However, the correlation weakened again after a decade, the researchers concluded after analysing the health data of over four million adults over the age of 50 in the UK.

Found in contaminated water, food and soil, Helicobacter pylori can easily spread from person to person through bodily fluids.

Around 40 per cent of Britons are estimated to carry the bug, which latches on to the sticky mucus of a carrier’s stomach.

While it is unlikely to cause any issues for most people, around 15 per cent of those affected may suffer from symptoms including stomach pains, nausea, weight loss and, potentially, and ulcers.

How exactly the bug increases the risk of Alzheimer’s disease is not known, but the McGill University research team suggested that it might be able to travel to the brain, where it inflames cells and cause neurodegeneration.

Dr Paul Brassard, the study’s senior author, has expressed hope that their findings could help protect people from Alzheimer’s, which affects around 900,000 people in Britain, in the future.

Dementia cases are expected to triple in the next 40 years, but there’s limited effective treatment options for this disease, Brassard added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less